Cargando…
MON-325 Co-Occurrence of Breast Cancer and Neuroendocrine Tumors: More Than a Coincidence?
Background: In Ontario, age-standardized incidence of female breast cancer was 145.1 per 100000/year in 2012. Neuroendocrine tumors (NET) are less common, with an incidence of 5.86 per 100000/year in 2009 in the same population. Evidence is scarce about the possible genetic mutations that may predis...
Autores principales: | Larouche, Vincent, Akirov, Amit, Kim, Raymond, Ezzat, Shereen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Endocrine Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6551061/ http://dx.doi.org/10.1210/js.2019-MON-325 |
Ejemplares similares
-
Co‐occurrence of breast cancer and neuroendocrine tumours: New genetic insights beyond Multiple Endocrine Neoplasia syndromes
por: Larouche, Vincent, et al.
Publicado: (2019) -
Management of Small Bowel Neuroendocrine Tumors
por: Larouche, Vincent, et al.
Publicado: (2019) -
Treatment Options for Pancreatic Neuroendocrine Tumors
por: Akirov, Amit, et al.
Publicado: (2019) -
SUN-325 A Neuroendocrine Tumor with Liver Metastases in a patient with Acid Peptic Disease
por: López Maldonado, Francisco, et al.
Publicado: (2019) -
MON-340 Concomitant TIO and SIADH in a Patient with Neuroendocrine Tumor
por: Rahhal, Marie-Noel, et al.
Publicado: (2019)